New bone graft shows promise for repairing Cancer-Damaged spines
Disease control
Completed
This study tested a new bone graft material, ZetaMet, in 10 women with breast cancer that spread to their spine, causing bone defects. The graft was implanted into the damaged vertebra to see if it could safely stabilize the spine and reduce pain. The main goals were to track com…
Phase: PHASE2 • Sponsor: Zetagen Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC